These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29189178)

  • 1. Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins.
    Iannelli F; Lombardi R; Milone MR; Pucci B; De Rienzo S; Budillon A; Bruzzese F
    Recent Pat Anticancer Drug Discov; 2018; 13(2):184-200. PubMed ID: 29189178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins: a repurposed drug to fight cancer.
    Jiang W; Hu JW; He XR; Jin WL; He XY
    J Exp Clin Cancer Res; 2021 Jul; 40(1):241. PubMed ID: 34303383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins as anti-tumor agents: A paradigm for repurposed drugs.
    Tripathi S; Gupta E; Galande S
    Cancer Rep (Hoboken); 2024 May; 7(5):e2078. PubMed ID: 38711272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovations in asthma therapy: is there a role for inhaled statins?
    Zeki AA; Elbadawi-Sidhu M
    Expert Rev Respir Med; 2018 Jun; 12(6):461-473. PubMed ID: 29575963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic effects of statins: A focus on cancer.
    Ahmadi M; Amiri S; Pecic S; Machaj F; Rosik J; Łos MJ; Alizadeh J; Mahdian R; da Silva Rosa SC; Schaafsma D; Shojaei S; Madrakian T; Zeki AA; Ghavami S
    Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165968. PubMed ID: 32927022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress.
    Kaymak I; Maier CR; Schmitz W; Campbell AD; Dankworth B; Ade CP; Walz S; Paauwe M; Kalogirou C; Marouf H; Rosenfeldt MT; Gay DM; McGregor GH; Sansom OJ; Schulze A
    Cancer Res; 2020 Jan; 80(2):189-203. PubMed ID: 31744820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin drugs, metabolic pathways, and asthma: a therapeutic opportunity needing further research.
    Zeki AA; Kenyon NJ; Goldkorn T
    Drug Metab Lett; 2011 Jan; 5(1):40-4. PubMed ID: 21198438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pitavastatin slows tumor progression and alters urine-derived volatile organic compounds through the mevalonate pathway.
    Wang L; Wang Y; Chen A; Teli M; Kondo R; Jalali A; Fan Y; Liu S; Zhao X; Siegel A; Minami K; Agarwal M; Li BY; Yokota H
    FASEB J; 2019 Dec; 33(12):13710-13721. PubMed ID: 31585508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed Drugs.
    Joharatnam-Hogan N; Alexandre L; Yarmolinsky J; Lake B; Capps N; Martin RM; Ring A; Cafferty F; Langley RE
    Curr Oncol Rep; 2021 Feb; 23(3):29. PubMed ID: 33582975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the Metabolic Response to Statin-Mediated Oxidative Stress Produces a Synergistic Antitumor Response.
    McGregor GH; Campbell AD; Fey SK; Tumanov S; Sumpton D; Blanco GR; Mackay G; Nixon C; Vazquez A; Sansom OJ; Kamphorst JJ
    Cancer Res; 2020 Jan; 80(2):175-188. PubMed ID: 31562248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins interfere with the attachment of
    Cirigliano A; Amelina A; Biferali B; Macone A; Mozzetta C; Bianchi MM; Mori M; Botta B; Pick E; Negri R; Rinaldi T
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):129-137. PubMed ID: 31694426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An endothelial SOX18-mevalonate pathway axis enables repurposing of statins for infantile hemangioma.
    Holm A; Graus MS; Wylie-Sears J; Borgelt L; Heng Tan JW; Nasim S; Chung L; Jain A; Sun M; Sun L; Brouillard P; Lekwuttikarn R; Kozakewich H; Qi JY; Teng JC; Mulliken JB; Vikkula M; Francois M; Bischoff J
    bioRxiv; 2024 Feb; ():. PubMed ID: 39026886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical statins as antifungals: a review.
    Khoury DM; Ghaoui N; El Tayar E; Dagher R; El Hawa M; Rubeiz N; Abbas O; Kurban M
    Int J Dermatol; 2024 Jun; 63(6):747-753. PubMed ID: 38344878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are statins onco- suppressive agents for every type of tumor? A systematic review of literature.
    Filaferro L; Zaccarelli F; Niccolini GF; Colizza A; Zoccali F; Grasso M; Fusconi M
    Expert Rev Anticancer Ther; 2024 Jun; 24(6):435-445. PubMed ID: 38609343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Tumor Microenvironment: A Literature Review of the Novel Anti-Tumor Mechanism of Statins.
    Zhu PF; Wang MX; Chen ZL; Yang L
    Front Oncol; 2021; 11():761107. PubMed ID: 34858839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential immunologic effects of statins in cancer following transplantation.
    Fildes JE; Shaw SM; Williams SG; Yonan N
    Cancer Immunol Immunother; 2009 Mar; 58(3):461-7. PubMed ID: 18523769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant attenuation of HMG-CoA reductase expression potentiates the cancer cell growth-inhibitory effect of statins and expands their efficacy in tumor cells with epithelial characteristics.
    Ishikawa T; Hosaka YZ; Beckwitt C; Wells A; Oltvai ZN; Warita K
    Oncotarget; 2018 Jun; 9(50):29304-29315. PubMed ID: 30034619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin as Repurposed Drug in Ovarian Cancer: A Comprehensive Review.
    Ahmad A; Javed S; Kiran S
    Curr Pharm Des; 2023; 29(27):2116-2123. PubMed ID: 37711112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the Prior Use of Statins on Head and Neck Cancer Risk: A Hospital-Based Case-Control Study.
    Saka-Herrán C; Jané-Salas E; Mano-Azul A; Torrejón-Moya A; Estrugo-Devesa A; López-López J
    Pharmaceuticals (Basel); 2022 May; 15(5):. PubMed ID: 35631405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Statins on Lung Cancer Molecular Pathways: A Possible Therapeutic Role.
    Marcianò G; Palleria C; Casarella A; Rania V; Basile E; Catarisano L; Vocca C; Bianco L; Pelaia C; Cione E; D'Agostino B; Citraro R; De Sarro G; Gallelli L
    Pharmaceuticals (Basel); 2022 May; 15(5):. PubMed ID: 35631415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.